President and CEO, Resolution Bioscience, USA
BIOGRAPHY
MAY 19, 2022 11:15 AM +08
Clinical Utility of Comprehensive NGS Liquid Biopsy Including Acquired Resistance Monitoring
Presented at:
Ignite Summit Series 2022
Speaker
You May Also Like
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
MAR 26, 2024 | 11:00 AM
Ever wonder what you’re missing in your data? The sheer complexity of today’s flow and mass cytometry datasets demands automated solutions. Machine learning plugins only provide...
NOV 29, 2023 | 9:00 AM
Tumor genomic profiling can be complicated, especially for diseases that commonly have multiple different genomic biomarkers of interest, such as non-small cell lung cancer (NSCLC) and color...
DEC 07, 2023 | 8:00 AM
As the vast landscape of genetic oncology continues to expand, the ability to understand and utilize the full potential of this rich data becomes increasingly challenging. As a result, resea...
FEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....
Loading Comments...
Finish Registering
-
MAY 07, 20243rd International Biosecurity Virtual Symposium -
MAY 23, 2024For the Love of Digital PCR 2024
-
JUN 06, 2024The Future of Scientific Conferencing
- See More
-
MAY 01, 2024
- See More
